Main
>
A1. CORP. INDEX. Nn-Nz
>
NovaLiq GmbH./P C2
NovaLiq GmbH./P C2's subsections
2011. 07.15. Funding
2013. 04.11. Funding
2013. 07.23. Dry Eye
2017. 12.06. Dry Eye
2019. 04.25. Glaucoma Betaliq Inc
2022. 01.18. Dermaliq Therapeutics
2023. 05.18. FDA Approval
2023. 06.08. FDA Approval
Web-Site
NovaLiq GmbH./P C2's products
This section has no products
2011. 07.15. Funding
2013. 04.11. Funding
2013. 07.23. Dry Eye
2017. 12.06. Dry Eye
2019. 04.25. Glaucoma Betaliq Inc
2022. 01.18. Dermaliq Therapeutics
2023. 05.18. FDA Approval
2023. 06.08. FDA Approval
Web-Site